TFX (Teleflex) NonCurrent Deferred Liabilities: $169 Mil (As of Mar. 2026)


TFX Teleflex Inc TFX
76 GF Score
Price $135.73
GF Value $181.91
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Teleflex NonCurrent Deferred Liabilities?

Teleflex TFX +1.26% 76 NonCurrent Deferred Liabilities is $169 Mil as of Mar. 2026. GuruFocus rates TFX with a GF Score™ of 76/100 and a GF Value™ of $181.91 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Teleflex's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $169 Mil.

Teleflex NonCurrent Deferred Liabilities Related Terms

Teleflex NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Teleflex's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex NonCurrent Deferred Liabilities Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 370.12 388.89 456.08 295.46 183.75

Teleflex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 385.67 373.96 423.65 183.75 169.43
TFX
76GF Score
Teleflex Inc TFX
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $169 Mil mean?
Teleflex (TFX) has a NonCurrent Deferred Liabilities of $169 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Teleflex and its competitors.
Is Teleflex's NonCurrent Deferred Liabilities too high?
Teleflex's current NonCurrent Deferred Liabilities is $169 Mil. Overall, Teleflex has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's NonCurrent Deferred Liabilities compare to STVN and AVTR?
Teleflex's NonCurrent Deferred Liabilities of $169 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Teleflex and its competitors. Teleflex's current NonCurrent Deferred Liabilities is $169 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (TFX) is currently considered Modestly Undervalued. The stock's GF Value™ is $181.91, compared to a current price of $135.73 — trading 25.4% below its estimated fair value. The current NonCurrent Deferred Liabilities is $169 Mil. Teleflex's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Teleflex (TFX), the current NonCurrent Deferred Liabilities is $169 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (TFX) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of $135.73 is trading 25.4% below its estimated GF Value™ of $181.91. GuruFocus considers Teleflex to be Modestly Undervalued.

Key valuation signals for TFX:

  • NonCurrent Deferred Liabilities: $169 Mil
  • GF Value™: $181.91 vs. price of $135.73 (25.4% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the TFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teleflex Business Description

Other Exchanges 1TFX:ItalyTBH:Germany
Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
76GF Score

Get the complete analysis for TFX

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$135.73
Price
$181.91
GF Value